Searchable abstracts of presentations at key conferences in obesity
Previous issue | Volume 2 | OU2020 | Next issue

Obesity Update 2020

London, UK
13 Feb 2020 - 13 Feb 2020

Card image cap
Obesity Update 2020 brings together a review of the last year, plenaries, debate and case discussions.

SPEAKER ABSTRACTS

Symposium: NASH & Type 2 diabetes

ob0002ou7 | Symposium: NASH & Type 2 diabetes | OU2020

Prevalence and Identification of NASH in type 2 diabetes

Armstrong Matthew

Non-alcoholic fatty liver disease (NAFLD) is the commonest cause of liver disease in the UK, with an estimated prevalence of 25% of the general population. It is a spectrum of disease ranging from simple liver steatosis, through to progressive liver inflammation (known as non-alcoholic steatohepatitis - NASH) and liver scar tissue (fibrosis). The latter can lead to thedevelopment of cirrhosis, liver failure and hepatocellular cancer (HCC). The main risk factors for NAFLD are t...